JAMA Cardiology·16 SepEfficacy and Safety of Semaglutide According to Frailty Status: A Post Hoc Analysis of the SELECT Randomized Clinical TrialRandomised trial in 17,604 peopleSemaglutidePaper
The Lancet Diabetes & Endocrinology·21 AugEfficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trialRandomised trial in 179 peopleOverweightPaper
ADA Scientific Sessions 2026 Abstract·7 JunType 1 Diabetes Multiancestry Polygenic Score (T1D MAPS) Is a Robust Predictor of Type 1 Diabetes Risk across Diverse PopulationsStudy in peopleBiomarkersPaper
ADA Scientific Sessions 2026 Abstract·6 JunType 2 Diabetes Incidence in Youth and Young Adults Aged 10–44 in the Diabetes in Children, Adolescents, and Young Adults Network (DiCAYA) Study, 2018–2023Study in peoplePopulationsPaper
ADA Scientific Sessions 2026 Abstract·5 JunEffect of Mazdutide on Kidney Function in Adults with Obesity or OverweightTrial in peopleInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunPulsed Electric Field–Induced Duodenal Recellularization Impact on Insulin Sensitivity and Beta-Cell Function—Results from REGENT-1, an Open-Label, Prospective Study in Type 2 DiabetesTrial in peopleInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunClinical Implementation of Polygenic Risk Scores for Cardio-Renal-Metabolic Disease—Uptake and Impact in a Large Community Health SystemStudy in peopleBiomarkersPaper